A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma MS Chen, JQ Li, Y Zheng, RP Guo, HH Liang, YQ Zhang, XJ Lin, WY Lau Annals of surgery 243 (3), 321-328, 2006 | 1839 | 2006 |
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study JW Park, M Chen, M Colombo, LR Roberts, M Schwartz, PJ Chen, ... Liver International 35 (9), 2155-2166, 2015 | 1300 | 2015 |
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients JP Zhang, J Yan, J Xu, XH Pang, MS Chen, L Li, C Wu, SP Li, L Zheng Journal of hepatology 50 (5), 980-989, 2009 | 733 | 2009 |
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition) J Zhou, H Sun, Z Wang, W Cong, J Wang, M Zeng, W Zhou, P Bie, L Liu, ... Liver cancer 9 (6), 682-720, 2020 | 696 | 2020 |
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial ZW Peng, YJ Zhang, MS Chen, L Xu, HH Liang, XJ Lin, RP Guo, ... Journal of clinical oncology 31 (4), 426-432, 2013 | 606 | 2013 |
Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition) J Zhou, HC Sun, Z Wang, WM Cong, JH Wang, MS Zeng, JM Yang, P Bie, ... Liver cancer 7 (3), 235-260, 2018 | 585 | 2018 |
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial M Shi, RP Guo, XJ Lin, YQ Zhang, MS Chen, CQ Zhang, WY Lau, JQ Li Annals of surgery 245 (1), 36-43, 2007 | 561 | 2007 |
Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized … MK He, QJ Li, RH Zou, JX Shen, WQ Fang, GS Tan, YM Zhou, XP Wu, ... JAMA oncology 5 (7), 953-960, 2019 | 501 | 2019 |
Genome-wide association study identifies 1p36. 22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers H Zhang, Y Zhai, Z Hu, C Wu, J Qian, W Jia, F Ma, W Huang, L Yu, W Yue, ... Nature genetics 42 (9), 755-758, 2010 | 437 | 2010 |
Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study J Luo, RP Guo, ECH Lai, YJ Zhang, WY Lau, MS Chen, M Shi Annals of surgical oncology 18, 413-420, 2011 | 436 | 2011 |
Chirality-controlled synthesis of single-wall carbon nanotubes using vapour-phase epitaxy J Liu, C Wang, X Tu, B Liu, L Chen, M Zheng, C Zhou Nature communications 3 (1), 1199, 2012 | 428 | 2012 |
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial Y Han, J Guo, Y Zheng, H Zang, X Su, Y Wang, S Chen, T Jiang, P Yang, ... Jama 313 (13), 1336-1346, 2015 | 419 | 2015 |
Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells DM Kuang, C Peng, Q Zhao, Y Wu, MS Chen, L Zheng Hepatology 51 (1), 154-164, 2010 | 341 | 2010 |
Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma: a randomized phase III trial QJ Li, MK He, HW Chen, WQ Fang, YM Zhou, L Xu, W Wei, YJ Zhang, ... Journal of Clinical Oncology 40 (2), 150-160, 2022 | 326 | 2022 |
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study ZW Peng, XJ Lin, YJ Zhang, HH Liang, RP Guo, M Shi, MS Chen Radiology 262 (3), 1022-1033, 2012 | 308 | 2012 |
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case … XJ Lin, Y Chong, ZW Guo, C Xie, XJ Yang, Q Zhang, SP Li, Y Xiong, ... The Lancet Oncology 16 (7), 804-815, 2015 | 296 | 2015 |
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2) L Jiao, HL Zhang, DD Li, KL Yang, J Tang, X Li, J Ji, Y Yu, RY Wu, ... Autophagy 14 (4), 671-684, 2018 | 276 | 2018 |
Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial ZW Peng, YJ Zhang, HH Liang, XJ Lin, RP Guo, MS Chen Radiology 262 (2), 689-700, 2012 | 261 | 2012 |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ... The Lancet 402 (10415), 1835-1847, 2023 | 235 | 2023 |
GWAS identifies novel susceptibility loci on 6p21. 32 and 21q21. 3 for hepatocellular carcinoma in chronic hepatitis B virus carriers S Li, J Qian, Y Yang, W Zhao, J Dai, JX Bei, JN Foo, PJ McLaren, Z Li, ... PLoS genetics 8 (7), e1002791, 2012 | 221 | 2012 |